Aon conducted an actuarial analysis of four Lyra customers’ medical and prescription drug spending incurred in 2018 and 2019 representing approximately 40,000 Lyra Employee Assistance Program (EAP) eligible members. The analysis utilized Aon’s member-level Cost Efficiency Measurement (CEM) methodology comparing the experience of members who utilized Lyra services (Lyra-engaged members) to that of a control group composed of Lyra eligible members with matching geography, demographics, and medical and mental health comorbidities for the same time periods.
Key findings based on the measurement include: